Eosinophil-guided therapy reduces steroids in COPD exacerbations
By Michael Woodhead
21 May 2019
Blood eosinophil counts could be used to guide reductions in systemic corticosteroid dosing in patients with acute exacerbations of COPD without compromising outcomes, a Danish study has shown. A randomised, open-label trial in 358 patients hospitalised with acute exacerbations showed that use of eosinophil-guided corticosteroid therapy reduced steroid duration from five days to two days ...